December 03, 2020
An impurity detected during routine testing has prompted Heritage Pharmaceuticals Inc. to recall a single lot of felodipine extended-release tablets, according to the December 2, 2020, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects 100-count bottles of felodipine extended-release tablets, 10 mg (NDC 23155-050-01), from lot 18029979 (Exp. 1/21). The affected tablets were distributed throughout the United States.
Heritage Pharmaceuticals voluntarily initiated the recall October 23, 2020. The FDA designated it Class III on November 25, 2020, suggesting use of the recalled tablets is not likely to cause harm.
Felodipine is a prescription medication used to treat high blood pressure.